Brief Summary
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advancedat a late stage, far along solid tumors.
Intervention / Treatment
- Drug: SQ3370
Inclusion Criteria
- Diagnosisthe process of identifying a disease based on signs and symptoms, patient history and medical test results of advanced soft tissuetissue/the material that joins, holds up or surrounds inside body parts such as fat, muscle, ligaments and lining around joints sarcomacancer arising from bones and/or soft tissue or other solid tumors
- Adequate hematologic, hepatic, renal, and coagulation function
- ECOG performance status score 0-1
- Tumor is the type where published clinical data would suggest that anthracyclines have cytotoxic activity
- Injectable tumor present